Literature DB >> 31641420

Patient Preferences and Comparative Outcomes Regarding Cryosurgery versus Electrodesiccation in the Removal of Truncal Seborrheic Keratoses.

Elizabeth Ethington1,2,3, Andia Mitri1,2,3, David Surprenant1,2,3, Michael Murphy1,2,3, Rebecca Rovner1,2,3, Jeave Reserva1,2,3, James Swan1,2,3, William Adams1,2,3, Rebecca Tung1,2,3, Kristin Lee1,2,3.   

Abstract

Background: Seborrheic keratoses (SKs) are one of the most common benign epithelial tumors seen by dermatologists. Many people elect to have these lesions removed, most commonly by way of cryosurgery or electrodesiccation. Objective: We sought to evaluate the comparative efficacy and patient preferences regarding cryosurgery and electrodesiccation for the treatment of truncal SK lesions.
Methods: In this randomized, blinded clinical trial, 33 eligible subjects with two similar truncal SKs were assigned to receive treatment with cryosurgery and electrodesiccation applied to separate lesions. Patients rated their pain and preference at the time of treatment and follow up at two and eight weeks. Physicians rated the color, texture, and efficacy of lesion removal at eight weeks.
Results: Patients did not have a treatment preference (p=0.10) and there was no significant difference in pain when comparing cryosurgery to electrodesiccation (p=0.43). Both treatment modalities were similar in terms of efficacy (p=0.50). Skin texture was rated similarly (p=0.64); however, lesions treated with cryosurgery were nominally less likely to have posttreatment hyperpigmentation compared to lesions treated with electrodesiccation (odds ratio: 0.35, 95% confidence interval: 0.12-1.002; p=0.0504).
Conclusion: Cryosurgery and electrodesiccation are both effective treatment modalities for truncal SKs. While cosmetic outcomes were similar, cryosurgery resulted in less postinflammatory hyperpigmentation.
Copyright © 2019. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Seborrheic keratoses; cryosurgery; electrodesiccation

Year:  2019        PMID: 31641420      PMCID: PMC6777698     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  15 in total

1.  Successful treatment of multiple seborrheic keratoses using acitretin.

Authors:  J P Thyssen; C Zachariae
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-02       Impact factor: 6.166

2.  Current Understanding of Seborrheic Keratosis: Prevalence, Etiology, Clinical Presentation, Diagnosis, and Management.

Authors:  J Mark Jackson; Andrew Alexis; Brian Berman; Diane S Berson; Susan Taylor; Jonathan S Weiss
Journal:  J Drugs Dermatol       Date:  2015-10       Impact factor: 2.114

3.  Ex vivo evaluation of cytotoxicity and melanocyte viability after A-101 hydrogen peroxide topical solution 40% or cryosurgery treatment in seborrheic keratosis lesions.

Authors:  Stephanie Kao; Alexi Kiss; Tatiana Efimova; Adam Friedman
Journal:  J Am Acad Dermatol       Date:  2018-03-27       Impact factor: 11.527

4.  The roles of vitamin D in seborrhoeic keratosis: possible genetic and cellular signalling mechanisms.

Authors:  K v q Lu'o'ng; L T H Nguyễn
Journal:  Int J Cosmet Sci       Date:  2013-08-05       Impact factor: 2.970

5.  Effectiveness of erbium:YAG laser and cryosurgery in seborrheic keratoses: Randomized, prospective intraindividual comparison study.

Authors:  Mehmet Salih Gurel; Burcak Bozdemir Aral
Journal:  J Dermatolog Treat       Date:  2015-03-23       Impact factor: 3.359

6.  A novel topical agent in the treatment of seborrheic keratoses: A proof of concept study by clinical and dermoscopic evaluation.

Authors:  Francesco Lacarrubba; Maria Rita Nasca; Anna Elisa Verzì; Giuseppe Micali
Journal:  Dermatol Ther       Date:  2017-08-10       Impact factor: 2.851

7.  A-101, a Proprietary Topical Formulation of High-Concentration Hydrogen Peroxide Solution: A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Dose-Response Profile in Subjects With Seborrheic Keratosis of the Face.

Authors:  Janet C DuBois; Michael Jarratt; Brian B Beger; Mark Bradshaw; Christopher V Powala; Stuart D Shanler
Journal:  Dermatol Surg       Date:  2018-03       Impact factor: 3.398

8.  Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents.

Authors:  Michaela Brenner; Vincent J Hearing
Journal:  Drug Discov Today Dis Mech       Date:  2008

9.  Diclofenac gel may be a new treatment option for seborrheic keratosis.

Authors:  Habibullah Aktaş; Can Ergin; Havva Özge Keseroğlu
Journal:  Indian Dermatol Online J       Date:  2016 May-Jun

10.  Inverted follicular keratosis successfully treated with imiquimod.

Authors:  Ayse Serap Karadag; Emin Ozlu; Tugba Kevser Uzuncakmak; Necmettin Akdeniz; Bengu Cobanoglu; Berkant Oman
Journal:  Indian Dermatol Online J       Date:  2016 May-Jun
View more
  1 in total

1.  Eruptive Seborrheic Keratoses Are Associated With a Co-Occurring Malignancy in the Majority of Reported Cases: A Systematic Review.

Authors:  Sara Mirali; Asfandyar Mufti; Rafael Paolo Lansang; Muskaan Sachdeva; Jensen Yeung
Journal:  J Cutan Med Surg       Date:  2021-11-28       Impact factor: 2.092

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.